← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2005Last known activity
Dec 8, 2021
Timeline
2000s
- Jun 1, 2001
Sprim Consulting— Founded
Drugs by trial phase (31 distinct, 27 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Clostridium Infections
- Communicable Diseases
- Constipation
- Diarrhea
- Dysentery
- Dyspepsia
- Gastrointestinal Diseases
- Infections
- Inflammation
- Influenza, Human
- Irritable Bowel Syndrome
- Lung Diseases, Obstructive
- Metabolic Syndrome
- Overweight
- Pulmonary Disease, Chronic Obstructive
- Signs and Symptoms, Digestive
- Syndrome
Recent trials (31)
- NCT05129384Overall official - principal investigatorN/ADec 8, 2021
- NCT04248699CollaboratorN/AJan 14, 2020
- NCT04248699Overall official - principal investigatorN/AJan 14, 2020
- NCT03772808Overall official - principal investigatorN/ANov 16, 2018
- NCT03596099CollaboratorN/AJul 31, 2018
- NCT03238534CollaboratorPhase 4Sep 12, 2017
- NCT03081845Study directorPhase 4Sep 13, 2016
- NCT03049579Study directorN/AJan 8, 2016
- NCT03081936Study directorPhase 4Nov 1, 2015
- NCT02128971CollaboratorPhase 2Apr 1, 2014
- NCT01953172CollaboratorN/AOct 1, 2013
- NCT01945970CollaboratorN/ASep 30, 2013
- NCT01724203CollaboratorN/ADec 1, 2012
- NCT01694680CollaboratorN/AOct 1, 2012
- NCT01545037Overall official - principal investigatorPhase 2/Phase 3Jul 1, 2012
Details
- Founded
- Orlando, FL, US Jun 1, 2001
- Last known activity
- Dec 8, 2021
Notes
CRO